X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (123) 123
index medicus (81) 81
oral sodium phenylbutyrate (78) 78
animals (67) 67
administration, oral (59) 59
male (51) 51
female (46) 46
oncology (44) 44
phenylbutyrates - pharmacology (35) 35
mice (33) 33
hematology (30) 30
histone deacetylase inhibitors (30) 30
pharmacology & pharmacy (30) 30
adult (28) 28
cancer (24) 24
apoptosis (22) 22
middle aged (21) 21
antineoplastic agents - pharmacology (20) 20
dose-response relationship, drug (20) 20
hydroxyurea (20) 20
phenylbutyrate (20) 20
therapy (19) 19
butyrate (18) 18
phenylbutyrates - administration & dosage (18) 18
suberoylanilide hydroxamic acid (18) 18
biochemistry & molecular biology (17) 17
expression (17) 17
fetal hemoglobin - biosynthesis (17) 17
phenylacetate (17) 17
research (17) 17
sickle-cell-anemia (17) 17
treatment outcome (17) 17
adolescent (16) 16
analysis (16) 16
anemia, sickle cell - drug therapy (16) 16
histone deacetylase (16) 16
care and treatment (15) 15
gene expression (15) 15
in-vivo (15) 15
article (14) 14
differentiation (14) 14
disease models, animal (14) 14
globin gene-expression (14) 14
histone deacetylase inhibitor (14) 14
neoplasms - drug therapy (14) 14
antineoplastic agents - therapeutic use (13) 13
beta-thalassemia (13) 13
cells (13) 13
child (13) 13
health aspects (13) 13
induction (13) 13
phenylbutyrates - therapeutic use (13) 13
proteins (13) 13
apoptosis - drug effects (12) 12
fetal hemoglobin (12) 12
rats (12) 12
valproic acid (12) 12
aged (11) 11
antineoplastic agents - administration & dosage (11) 11
beta-thalassemia - drug therapy (11) 11
clinical trials (11) 11
clinical-trial (11) 11
disease (11) 11
enzyme inhibitors - pharmacology (11) 11
histones - metabolism (11) 11
medicine (11) 11
medicine & public health (11) 11
oral administration (11) 11
anemia, sickle cell - blood (10) 10
histones (10) 10
hydroxamic acids - pharmacology (10) 10
multidisciplinary sciences (10) 10
pharmacology/toxicology (10) 10
phase-i (10) 10
phenylbutyrates - chemistry (10) 10
physiological aspects (10) 10
research article (10) 10
rodents (10) 10
sickle cell anemia (10) 10
sodium phenylbutyrate (10) 10
tumor cells, cultured (10) 10
biological availability (9) 9
cell biology (9) 9
drug therapy, combination (9) 9
fetal hemoglobin production (9) 9
gene expression regulation - drug effects (9) 9
gene-expression (9) 9
histone deacetylase inhibitors - pharmacology (9) 9
hydroxyurea - therapeutic use (9) 9
immunology (9) 9
inflammation (9) 9
mice, inbred c57bl (9) 9
pharmacokinetics (9) 9
phase-ii trial (9) 9
phenylbutyrates - pharmacokinetics (9) 9
acetylation - drug effects (8) 8
anemia (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
beta-thalassemia - genetics (8) 8
butyrates - therapeutic use (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 03/2013, Volume 288, Issue 12, pp. 8299 - 8312
Neurotrophins, such as brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are believed to be genuine molecular mediators of neuronal growth... 
GEMFIBROZIL | PHENYLACETATE | BDNF | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | PHASE-I | EXPRESSION | BRAIN | MULTIPLE | LIPID-LOWERING DRUG | FAMILY | Memory - drug effects | Brain-Derived Neurotrophic Factor - genetics | Brain-Derived Neurotrophic Factor - secretion | Phosphorylation | Humans | Male | Neurotrophin 3 - genetics | Receptors, Nerve Growth Factor - metabolism | Glial Fibrillary Acidic Protein - metabolism | Cell Shape | Phenylbutyrates - administration & dosage | Phenylbutyrates - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Neurons - metabolism | Neurons - drug effects | Alzheimer Disease - psychology | Neurotrophin 3 - secretion | Astrocytes - drug effects | Administration, Oral | Mice, Inbred C57BL | Cells, Cultured | Alzheimer Disease - drug therapy | Mice, Transgenic | Hippocampus - pathology | Receptors, Nerve Growth Factor - genetics | Up-Regulation - drug effects | Astrocytes - physiology | Animals | Neurotrophin 3 - metabolism | Formates - pharmacology | Alzheimer Disease - metabolism | Cyclic AMP Response Element-Binding Protein - metabolism | Mice | Protein Processing, Post-Translational | Primary Cell Culture | Astrocytes - metabolism | Protein Kinase C | Brain-derived Neurotrophic Factor (BDNF) | CREB | Neurotrophins | Synaptic Plasticity | Protein Kinase C (PKC) | Neurobiology
Journal Article
Journal Article
Journal Article
Paediatric drugs, 04/2016, Volume 18, Issue 2, p. 139
The aim was to describe the status of patients with urea cycle disorders (UCD) at the latest long-term clinical follow-up of treatment with a new taste-masked... 
Follow-Up Studies | Administration, Oral | Humans | Phenylbutyrates - administration & dosage | Quality of Life | Taste | Patient Compliance | Urea Cycle Disorders, Inborn - drug therapy | Chemistry, Pharmaceutical | Health Care Surveys
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 02/2008, Volume 50, Issue 2, pp. 357 - 359
Journal Article
EUROPEAN JOURNAL OF HUMAN GENETICS, ISSN 1018-4813, 05/2017, Volume 25, pp. S68 - S72
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease, characterized by degeneration of the anterior horn cells of the spinal cord. SMA... 
SURVIVAL | CELLS | PROTEIN | PHENYLACETATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | GENE-EXPRESSION | PROLIFERATION | IDENTIFICATION | ORAL SODIUM PHENYLBUTYRATE | SINGLE NUCLEOTIDE | SEVERITY
Journal Article
Cancer Research, ISSN 0008-5472, 06/2006, Volume 66, Issue 12, pp. 6361 - 6369
Optimal reexpression of most genes silenced through promoter methylation requires the sequential application of DNA methyltransferase inhibitors followed by... 
ACUTE-LEUKEMIA | CYTIDINE DEAMINASE GENE | CPG ISLAND METHYLATION | ONCOLOGY | ARA-C SENSITIVITY | HYPOMETHYLATING AGENT | COLORECTAL-CANCER | RISK MYELODYSPLASTIC SYNDROME | LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE | ORAL SODIUM PHENYLBUTYRATE | ELDERLY-PATIENTS | Azacitidine - adverse effects | Humans | Leukemia, Myeloid - genetics | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Phenylbutyrates - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Feasibility Studies | Myelodysplastic Syndromes - enzymology | Dose-Response Relationship, Drug | Phenylbutyrates - pharmacokinetics | Phenylbutyrates - administration & dosage | Aged, 80 and over | Female | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | Promoter Regions, Genetic | Acute Disease | Azacitidine - pharmacokinetics | Myelodysplastic Syndromes - metabolism | Histone Deacetylases - genetics | Leukemia, Myeloid - enzymology | Treatment Outcome | DNA (Cytosine-5-)-Methyltransferases - genetics | Leukemia, Myeloid - drug therapy | Acetylation - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Leukemia, Myeloid - metabolism | Aged | Histone Deacetylase Inhibitors | Myelodysplastic Syndromes - genetics | Histones - metabolism | DNA Methylation - drug effects
Journal Article
European Journal of Human Genetics, ISSN 1018-4813, 01/2004, Volume 12, Issue 1, pp. 59 - 65
Journal Article
WORLD JOURNAL OF GASTROENTEROLOGY, ISSN 1007-9327, 03/2011, Volume 17, Issue 12, pp. 1519 - 1528
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.